LCTX | Lineage Cell Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1998-06-30	1997-06-30	1996-06-30	1995-06-30
Revenue	8.95M	14.70M	3.90M	773.00K	1.48M	1.42M	3.46M	5.92M	7.04M	5.24M	4.43M	3.92M	4.35M	3.68M	1.93M	1.50M	1.05M	1.16M	903.20K	688.38K	556.42K	387.02K	151.92K	52.49K	1.04M	300.00K	1.20M	100.00K	100.00K	100.00K
Cost of Revenue	1.36M	728.00K	1.43M	385.00K	412.00K	302.00K	168.00K	358.00K	1.11M	837.05K	792.66K	434.27K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-75.46K	-59.54K	N/A	N/A	N/A	N/A	N/A
Gross Profit	7.58M	13.97M	2.47M	388.00K	1.07M	1.11M	3.29M	5.57M	5.93M	4.41M	3.64M	3.48M	4.35M	3.68M	1.93M	1.50M	N/A	1.16M	903.20K	N/A	556.42K	N/A	N/A	127.95K	1.10M	N/A	N/A	N/A	N/A	N/A
Operating Expenses	32.31M	36.49M	51.68M	26.84M	39.94M	42.11M	43.95M	64.53M	71.74M	55.09M	42.17M	28.48M	23.04M	13.53M	5.45M	4.33M	2.27M	2.91M	2.92M	2.66M	2.25M	2.42M	3.65M	5.22M	6.86M	2.40M	4.80M	3.30M	N/A	N/A
Selling, General & Admin	16.74M	22.51M	18.21M	15.57M	24.03M	24.73M	19.92M	28.43M	29.13M	17.56M	15.56M	10.37M	9.34M	5.64M	2.48M	2.62M	1.30M	1.49M	1.40M	1.48M	1.26M	1.32M	1.96M	1.78M	1.90M	700.00K	1.80M	1.20M	2.10M	800.00K
Research & Development	15.57M	13.99M	33.91M	12.32M	17.95M	20.95M	24.02M	36.11M	42.60M	37.53M	26.61M	18.12M	13.70M	7.89M	2.97M	1.71M	967.86K	1.42M	1.53M	1.12M	903.02K	1.10M	1.69M	3.36M	4.90M	1.70M	3.00M	2.10M	N/A	1.80M
Other Operating Expenses	-4.00K	-2.15M	-445.00K	-1.05M	-2.04M	-1.31M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	49.52K	82.52K	N/A	N/A	75.46K	59.54K	N/A	N/A	N/A	N/A	N/A
Operating Income	-24.73M	-22.52M	-49.21M	-26.45M	-38.88M	-41.80M	-38.90M	-58.97M	-65.81M	-50.68M	-38.53M	-25.00M	-18.69M	-9.85M	-3.52M	-2.82M	-1.22M	-1.75M	-2.02M	-1.97M	-1.69M	-2.03M	-3.49M	-5.09M	-5.76M	-2.10M	-3.60M	-3.20M	-2.00M	-2.50M
Other Expenses / Income	1.45M	-3.29M	5.94M	4.52M	19.64M	-6.85M	15.61M	77.59M	3.16M	-472.14K	-17.66M	-305.18K	212.82K	-2.21M	30.11K	7.52K	16.93K	44.36K	23.14K	32.34K	1.04M	20.65K	114.34K	165.26K	279.83K	100.00K	300.00K	200.00K	100.00K	200.00K
Before Tax Income	-23.28M	-25.81M	-43.27M	-21.92M	-19.23M	-47.13M	-23.29M	18.62M	-62.65M	-51.15M	-56.19M	-25.31M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax Expenses	-1.80M	541.00K	-4.71M	-1.24M	-7.41M	-346.00K	N/A	N/A	-4.52M	-7.38M	-3.28M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-21.49M	-26.35M	-38.56M	-20.68M	-11.83M	-45.99M	-19.98M	33.57M	-46.99M	-36.41M	-43.88M	-21.43M	-16.52M	-11.18M	-5.14M	-3.78M	-1.44M	-1.86M	-2.07M	-3.09M	-1.74M	-2.84M	-3.66M	-4.93M	-5.48M	-2.10M	-3.50M	-3.00M	-2.00M	-2.40M
Interest Expenses	N/A	5.18M	N/A	N/A	1.69M	10.87M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	124.30K	1.65M	965.78K	N/A	157.11K	78.98K	N/A	1.09M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Basic Shares Outstanding	172.66M	169.79M	164.50M	150.04M	145.53M	126.90M	114.48M	97.32M	79.71M	66.47M	54.23M	49.21M	47.49M	40.27M	29.30M	23.75M	22.85M	22.54M	17.90M	17.45M	14.26M	12.37M	11.56M	11.04M	10.69M	10.00M	9.83M	8.88M	7.83M	8.00M
Diluted Shares Outstanding	172.66M	169.79M	164.50M	150.04M	145.53M	126.90M	114.48M	99.55M	79.71M	66.47M	54.23M	49.21M	47.49M	40.27M	29.30M	23.75M	22.85M	22.54M	17.90M	17.45M	14.26M	12.37M	11.56M	11.04M	10.69M	10.00M	10.00M	8.88M	8.33M	8.00M
EBITDA	-24.04M	-19.82M	-52.79M	-25.01M	-54.30M	-32.19M	-16.68M	38.33M	-45.17M	-35.38M	-43.21M	-18.59M	-14.15M	-10.13M	-3.46M	-2.80M	-1.63M	-1.68M	-1.99M	-2.04M	159.12K	-2.34M	-3.36M	-4.85M	-5.42M	-2.10M	-3.50M	-3.00M	-2.00M	-2.40M
EBITDA Margin	-268.76%	-134.83%	-1,355.01%	-3,235.71%	-3,673.95%	-2,273.38%	-482.36%	647.12%	-642.03%	-674.72%	-974.47%	-474.86%	-324.91%	-275.29%	-179.49%	-186.09%	-155.57%	-144.66%	-220.21%	-295.84%	28.60%	-604.15%	-2,213.85%	-9,238.68%	-522.44%	-700.00%	-291.67%	-3,000.00%	-2,000.00%	-2,400.00%
EBIT	-23.29M	-20.63M	-43.27M	-21.92M	-17.55M	-35.46M	-19.98M	33.57M	-51.51M	-43.79M	-47.16M	-21.43M	-16.52M	-11.06M	-3.49M	-2.82M	-1.44M	-1.71M	-2.00M	-3.09M	-651.46K	-2.84M	-3.66M	-4.93M	-5.48M	-2.10M	-3.50M	-3.00M	-2.00M	-2.40M
EBIT Margin	-260.36%	-140.32%	-1,110.63%	-2,836.22%	-1,187.35%	-2,504.52%	-577.67%	566.81%	-732.05%	-835.12%	-1,063.60%	-547.23%	-379.25%	-300.53%	-181.29%	-187.20%	-137.48%	-146.94%	-220.91%	-448.20%	-117.08%	-735.09%	-2,408.44%	-9,382.43%	-528.18%	-700.00%	-291.67%	-3,000.00%	-2,000.00%	-2,400.00%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1998-06-30	1997-06-30	1996-06-30	1995-06-30